Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT00287859
Eligibility Criteria:
Inclusion Criteria:
* Histological diagnosis of ovarian epithelial, fallopian tube, or primary peritoneal cavity cancer
* Progressive or recurrent disease
* Received ≥ 1 prior course of chemotherapy
* Measurable or evaluable disease OR disease assessable by CA 125, defined as CA 125 \> normal that has increased over 2 readings \> 14 days apart
* Karnofsky performance status 10-50%
* Absolute neutrophil count ≥ 1,500/mm\^3
* Platelet count ≥ 100,000/mm\^3
* Creatinine ≤ 1.5 mg/dL
* Alkaline phosphatase ≤ 3 times upper limit of normal (ULN)
* Total bilirubin ≤ 1.5 times ULN
* SGOT ≤ 3 times ULN
* Life expectancy ≥ 12 weeks
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use accepted and effective non-hormonal contraception
Exclusion Criteria:
* Other neoplasm within the past 5 years except for nonmetastatic, nonmelanoma skin cancers, carcinoma in situ of the cervix, or cancer cured by surgery or chemotherapy
* Septicemia, severe infection, or acute hepatitis
* Severe gastrointestinal bleeding, defined as requiring a blood transfusion or hospitalization
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00287859
Study Brief:
Protocol Section:
NCT00287859